Bioeureka
Bioeureka is a Montreal-based AI diagnostics company that provides food safety, clinical, and environmental laboratories with an AI-powered pathogen identification platform (AIMO) paired with a proprietary culture medium (MicroSelect), reducing per-test costs from $43-72 to $4.99 and turnaround times by 85%.
- Company typePrivate
- Founded2022
- HeadquartersMontréal, Canada
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Bioeureka does
Bioeureka (legal name: TECHNOLOGIE BIOEUREKA INC.) is a Canadian diagnostics technology company founded in 2022 and headquartered in Montreal, with R&D operations in Ottawa. The company has developed an integrated platform that combines AI software (AIMO) with a proprietary consumable culture medium (MicroSelect) to automate microbiological pathogen detection for food safety, clinical diagnostics, environmental testing, and academic research laboratories. AIMO is a computer vision and deep learning platform trained on millions of annotated pathogen images (covering E. coli, Salmonella, Listeria, Campylobacter, yeasts, and moulds) that identifies microorganisms from microscopic images within seconds after incubation, reportedly achieving accuracy above 95% and producing audit-ready compliance reports with confidence scores. MicroSelect is a tri-compartment 100mm Petri dish combining TSA with 5% sheep blood, MacConkey agar, and Mannitol Salt Agar on a single plate, engineered to shorten culture time and produce images optimized for the AI analysis.
The company monetizes through a hybrid model: SaaS-style subscriptions and pay-per-test pricing ($4.99 per test, compared to $43-72 at reference labs), consumable sales of MicroSelect plates, and a freemium acquisition funnel offering 500 free analyses per month plus a 30-day free trial. Distribution combines a self-serve web portal (app.bioeureka.com) with direct enterprise sales, plus a Canadian lab-services channel for SIAL/SFCA compliance testing. Go-to-market is product-led for SMB and individual users and sales-led for enterprise and mid-market accounts, supported by trade show presence (SIAL Canada), an ROI calculator, and white-paper content marketing.
Bioeureka is private, has no disclosed revenue, and has raised approximately $1.75M in cumulative funding across five rounds from 2022 to 2024. The platform only began commercial operations in April 2025. Key strategic partners include Mila, IVADO, University of Ottawa, NRC (CNRC), Centech, Chrono Innovation, and BioLab Ottawa. The company has been recognized as an elite Canadian medtech company by AdvaMed and has received multiple regional innovation awards.
Bioeureka firmographics
Firmographics- Name
- Bioeureka
- Legal name
- TECHNOLOGIE BIOEUREKA INC.
- Website
- https://bioeureka.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Bioeureka is a Montreal-based AI diagnostics company that provides food safety, clinical, and environmental laboratories with an AI-powered pathogen identification platform (AIMO) paired with a proprietary culture medium (MicroSelect), reducing per-test costs from $43-72 to $4.99 and turnaround times by 85%.
- Ownership category
- akta.pro rank
Bioeureka industry classification
Industry- Product category
- AI-driven microbiological diagnostics
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Process Analytical Technology (PAT) & In-Line/At-Line Analytics (spectroscopy, sensors, monitoring) (HLAAAJAD)
- akta.pro secondary industry
- Cell-Based & Potency Assays (Bioassays) (HLAGADAH)
Keywords
Where Bioeureka is headquartered
LocationHeadquarters
- HQ city
- Montréal
- HQ country
- Canada
- HQ region
- North America
Offices3 records
Markets served
Bioeureka business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- SaaS Subscriptions (AIMO Platform): Cloud-based AI platform subscription for pathogen identification and analysis. Users pay per test or through subscription plans based on usage volume. The platform generates audit-ready reports and confidence scores.
- Consumables (MicroSelect): Proprietary culture medium plates sold as consumables. Designed to work exclusively with the AIMO platform, creating a hardware-software ecosystem. A laboratory analyzing 100 isolates per month can save more than $7,500 per year in consumables.
- Freemium/Trial Revenue Conversion: 500 free analyses per month for new users, with 30-day free trial available. Conversion from free tier to paid subscriptions represents the primary customer acquisition revenue flow.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | Freemium - 500 free analyses per month |
| Usage-based | Pay-as-you-go | Pay-per-test model |
| Freemium | Monthly | 30-day free trial |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels8 records
Bioeureka product offering
Product offeringCore offering
Bioeureka provides an AI-powered pathogen identification platform that combines the AIMO cloud software with the MicroSelect proprietary culture medium to automate microbiological detection. The solution analyzes microscopic images of bacterial colonies within minutes of incubation, delivering 95%+ accuracy, audit-ready compliance reports, and per-test costs of $4.99 versus $43–$72 for reference labs, targeting food safety, clinical diagnostics, environmental, and academic laboratories.
Product overview
Bioeureka offers a unified platform combining AI software (AIMO) with a proprietary consumable (MicroSelect) to automate microbiological detection for food safety and applied microbiology. The platform is designed to integrate seamlessly into existing laboratory workflows, requiring only a standard microscope, camera, and computer. AIMO provides AI-powered pathogen identification from microscopic images, while MicroSelect serves as the optimized culture medium that enables faster, more reliable microbial selection and better imaging results for the AI analysis.
Differentiator
Problem solved
Functional benefit
Brands
- AIMO: AI platform for microbiological image recognition that identifies pathogens and microorganisms in seconds after incubation with accuracy above 95%, generating audit-ready compliance reports with confidence scores.
- MicroSelect™
Products and services
- AIMO AI-powered cloud platform dedicated to microbiological image recognition; trained on millions of images of pathogens and microorganisms, identifies colonies within seconds after incubation with accuracy above 95% and automatically generates audit-ready reports with confidence scores for food safety, clinical diagnostics, environmental testing, and academic laboratories.
- MicroSelect Optimized tri-compartment Petri dish (100mm) combining TSA with 5% sheep blood, MacConkey agar, and Mannitol Salt Agar on a single plate; designed to work with AIMO to shorten culture time and improve image quality for AI analysis. Storage at 2–8°C with a 6-month shelf life.
Quantifiable outcome
- Reduces cost per test from $43-72 to $4.99 (90%+ savings)
- +6 more outcomes
Companies that use Bioeureka
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles4 records
Bioeureka technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability5 records
Feature4 records
Bioeureka partnerships and signals
Strategic signalPartnerships
14 partnerships are on record, tiered core and minor.
- Université d'Ottawa (University of Ottawa)coreStrategic R&D partnership for development and validation of AI-powered pathogen detection technology. The university provides scientific expertise and laboratory facilities for testing and refining the platform.
- Mila (Quebec AI Institute)coreCollaboration with Mila for AI model development and deep learning expertise for pathogen identification algorithms.
- IVADO (Institute for Data-Driven Valorization)corePartnership with IVADO for data science expertise and research collaboration in AI for microbiology.
- CentechcoreSelected for Centech Propulsion accelerator program, providing mentorship, resources, and validation support for the startup.
- Chrono Innovation (Montreal)corePartnership for innovation and development activities in Montreal, contributing to platform development and testing.
- CNRC (National Research Council Canada)coreCollaboration with NRC for industrial technology advisory and potential regulatory pathway support.
- Invest OttawaminorOttawa-based innovation support organization providing resources and connections for company growth.
- Économie et Innovation QuébecminorQuebec government organization supporting innovation and economic development in the province.
- BioLab OttawacoreInitial testing and validation of the Bioeureka platform conducted at BioLab Ottawa facilities.
- GénieLab OttawacoreOttawa-based innovation lab contributing to technology development and validation.
- AXEO (programme Élévation)minorBusiness development support through the AXEO Elevation program.
- LaveryminorQuebec law firm providing legal advisory services.
- OSEDEAminorTechnology partner contributing to platform development.
- INNOVACITÉminorInnovation ecosystem partner supporting company growth.
Scale indicators8 records
Recent moves6 records
Expansion highlights5 records
Bioeureka competitors and assessment
Company assessmentDirect peers
- bioMérieux: Global leader in microbiological diagnostics and industrial microbiology. Directly comparable as it sells automated pathogen identification platforms and culture media into the same food safety, clinical and industrial testing customers that Bioeureka targets.
- Hygiena: Specialist in rapid food safety and environmental pathogen testing, including ATP and molecular diagnostics. Closely overlaps with Bioeureka's food-safety testing focus and serves similar food processing and QA laboratories.
- Bio-Rad Laboratories: Life science and clinical diagnostics company with strong microbiology and food safety testing offerings. Directly comparable as it sells both laboratory instruments and consumables used for pathogen identification workflows.
Broad incumbents
- Neogen (formerly 3M Food Safety): Established food safety and animal safety diagnostics provider offering pathogen detection kits, instruments and consumables. Comparable as a broad incumbent addressing the same food-safety testing use cases with a wider product portfolio.
- Becton, Dickinson and Company (BD): Major life sciences and diagnostics company with a large microbiology and clinical diagnostics franchise (BD MAX, BD Phoenix). Overlaps with Bioeureka in automated microbial identification and consumable culture media used in clinical labs.
- Thermo Fisher Scientific: Global life sciences tools leader with microbiology instruments, consumables and analytical software. Broad incumbent providing competing laboratory analytical instruments and services for pathogen testing.
Emerging players
- Specific Diagnostics: Emerging player in rapid phenotypic antimicrobial susceptibility testing and microbial identification. Comparable as an early-stage company applying novel sensing/automation to accelerate microbiology lab workflows.
- Roka BioScience (now part of bioMérieux): Developed molecular pathogen detection assays for food safety; comparable as a focused player in rapid food pathogen testing that ultimately highlighted both the opportunity and consolidation risk in this space.
- Clever Culture Systems (APAS Independence): Applies AI and computer vision to automated culture-plate reading in microbiology labs. Highly comparable as a niche AI-for-microbiology peer addressing the same workflow of automating pathogen identification from plate images.
Regional players
- Mérieux NutriSciences: Food testing and certification services network with strong global but regionally anchored operations. Comparable as a service-side peer providing outsourced microbiological testing that Bioeureka's in-house platform aims to disintermediate.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Bioeureka social profiles
Digital presenceBioeureka compliance and trust
Trust signalCompliance3 records
Bioeureka financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bioeureka leadership team
Management profileNumber of profiles
Profiles9 records
Bioeureka funding detail
Funding detailFunding overview
Funding rounds5 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bioeureka M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bioeureka
What does Bioeureka do?
Bioeureka provides an AI-powered pathogen identification platform that combines the AIMO cloud software with the MicroSelect proprietary culture medium to automate microbiological detection. The solution analyzes microscopic images of bacterial colonies within minutes of incubation, delivering 95%+ accuracy, audit-ready compliance reports, and per-test costs of $4.99 versus $43–$72 for reference labs, targeting food safety, clinical diagnostics, environmental, and academic laboratories.
Is Bioeureka a public or private company?
Bioeureka is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Bioeureka founded?
Bioeureka was founded in 2022. It employs 11 to 50 people.
Where is Bioeureka based?
Bioeureka is headquartered in Montréal, Canada, in the North America region.
How does Bioeureka make money?
Three revenue lines are on record. SaaS Subscriptions (AIMO Platform) is the primary driver. The others are consumables (MicroSelect) and freemium/Trial Revenue Conversion.
Who are Bioeureka's main competitors?
Direct peers on record are bioMérieux, Hygiena and Bio-Rad Laboratories. Broad incumbents are Neogen (formerly 3M Food Safety), Becton, Dickinson and Company (BD) and Thermo Fisher Scientific. Emerging players are Specific Diagnostics, Roka BioScience (now part of bioMérieux) and Clever Culture Systems (APAS Independence). Mérieux NutriSciences is listed as a regional player.
Does Bioeureka have an API?
No public API is recorded for Bioeureka.
What industry is Bioeureka in?
Bioeureka's product category is AI-driven microbiological diagnostics. Its primary akta.pro industry code is HLAAAJAD, Process Analytical Technology (PAT) & In-Line/At-Line Analytics (spectroscopy, sensors, monitoring), with a secondary code of HLAGADAH, Cell-Based & Potency Assays (Bioassays). Its NAICS code is 334516 and its SIC code is 2835.